Ahrens Investment Partners LLC - NEUBERGER BERMAN HGH YLD FD ownership

NEUBERGER BERMAN HGH YLD FD's ticker is NHS and the CUSIP is 64128C106. A total of 51 filers reported holding NEUBERGER BERMAN HGH YLD FD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Ahrens Investment Partners LLC ownership history of NEUBERGER BERMAN HGH YLD FD
ValueSharesWeighting
Q1 2022$34,000
-54.7%
3,000
-50.0%
0.01%
-66.7%
Q4 2021$75,000
-38.0%
6,000
-45.0%
0.03%
-59.3%
Q3 2020$121,000
+0.8%
10,900
-0.9%
0.08%
+80.0%
Q3 2018$120,000
-9.1%
11,000
-9.8%
0.04%
-18.2%
Q2 2018$132,000
+18.9%
12,200
+22.0%
0.06%
+14.6%
Q1 2018$111,00010,0000.05%
Other shareholders
NEUBERGER BERMAN HGH YLD FD shareholders Q4 2018
NameSharesValueWeighting ↓
ROBINSON CAPITAL MANAGEMENT, LLC 170,350$2,024,0000.93%
Saba Capital Management, L.P. 758,703$9,013,0000.81%
Shaker Financial Services, LLC 115,971$1,378,0000.78%
Yorktown Management & Research Co Inc 207,000$2,459,0000.64%
RIVERNORTH CAPITAL MANAGEMENT, LLC 487,712$5,794,0000.40%
DOLIVER ADVISORS, LP 26,270$312,0000.25%
Wunderlich Capital Managemnt 21,483$255,0000.20%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 149,089$1,745,0000.17%
SHEPHERD KAPLAN KROCHUK, LLC 20,000$238,0000.12%
Advisors Asset Management, Inc. 486,438$5,779,0000.10%
View complete list of NEUBERGER BERMAN HGH YLD FD shareholders